Profitability
Weight: 15%
F
0
- 5yr Avg ROIC -61.5%
MDGL
Madrigal Pharmaceuticals, Inc.
AlphaQuality composite grade, weighted for high-growth software businesses.
⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a high-growth software business.
Grade overrides the 12.7 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
0
- 5yr Avg ROE -94.9%
- 5yr Share-Count CAGR 7.8%
Growth Quality
Weight: 35%
F
20
- Revenue-Growth Years (5) 1/5
Cash Generation
Weight: 20%
F
0
- 5yr FCF Margin -136.8%
- 5yr FCF/NI Conversion 0.00x
Balance Sheet
Weight: 10%
F
25
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) -11.92x
- Altman Z-Score 9.54
Stability
Weight: 5%
B-
64
- Negative-Revenue Years (5) 0/5
- Piotroski F-Score 3
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.2 of 3 gurus held; 1 trimmed; 1 full exit.
- Holders
- 2 -1
- Avg Δ position
- -25.6%
- New buys
- 0
- Full exits
- 1